PHARMACOKINETICS OF METRONIDAZOLE IN HEALTHY ADULT VOLUNTEERS AFTER TABLETS AND SUPPOSITORIES

被引：39

作者：

BERGAN, T ^{[1
]}

ARNOLD, E ^{[1
]}

机构：

[1] AS DUMEX,DEPT BIOL,COPENHAGEN,DENMARK

来源：

CHEMOTHERAPY | 1980年 / 26卷 / 04期

关键词：

D O I：

10.1159/000237911

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：231 / 241

页数：11

共 15 条

[1]

CONNOR TH, 1977, CANCER RES, V37, P629

[2] METABOLISM OF METRONIDAZOLE (1-2'-HYDROXYETHYL-2-METHYL-5-NITROIMIDAZOLE) [J].

INGS, RMJ ;

LAW, GL ;

PARNELL, EW .

BIOCHEMICAL PHARMACOLOGY, 1966, 15 (05) :515-&

[3]

KANE PO, 1961, BRIT J VENER DIS, V37, P273

[4] ANTI-TRICHOMONAD ACTION, MUTAGENICITY, AND REDUCTION OF METRONIDAZOLE AND OTHER NITROIMIDAZOLES [J].

LINDMARK, DG ;

MULLER, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (03) :476-482

[5]

MCFADZEAN JA, 1969, BRIT J VENER DIS, V45, P161

[6]

MCGILVERAY IJ, 1978, INT J CLIN PHARM BI, V16, P110

[7] BIOAVAILABILITY OF METRONIDAZOLE IN FASTING AND NON-FASTING HEALTHY SUBJECTS AND IN PATIENTS WITH CROHNS-DISEASE [J].

MELANDER, A ;

KAHLMETER, G ;

KAMME, C ;

URSING, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (01) :69-72

[8]

Monro A M, 1974, Curr Med Res Opin, V2, P130, DOI 10.1185/03007997409113627

[9]

Nielsen M L, 1977, Scand J Gastroenterol, V12, P1003

[10] PHARMACOKINETICS OF METRONIDAZOLE AS DETERMINED BY BIOASSAY [J].

RALPH, ED ;

CLARKE, JT ;

LIBKE, RD ;

LUTHY, RP ;

KIRBY, WMM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (06) :691-696

← 1 2 →